The FDA has approved a new inhaled antibiotic to treat cystic fibrosis (CF) patients infected with Pseudomonas aeruginosa.
The FDA has approved a new inhaled antibiotic to treat cystic fibrosis (CF) patients infected with Pseudomonas aeruginosa.
Aztreonam for Inhalation (Cayston®)
April 30, 2010